Results 321 to 330 of about 1,849,608 (371)

Long-term Dynamics of Measles Virus-Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age. [PDF]

Clin Infect Dis
van der Staak M, Ten Hulscher HI, Nicolaie AM, Smits GP, de Swart RL, de Wit J, Rots NY, van Binnendijk RS.   +7 more
europepmc   +1 more source

Mucosal‐associated invariant T cells in rheumatic diseases.

Arthritis &Rheumatology, Accepted Article.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor (TCR) and restriction by the MHC class I‐related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines. Upon activation, MAIT cells rapidly produce pro‐inflammatory cytokines,
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

Molecular characteristics of the immune escape of coronavirus PEDV under the pressure of vaccine immunity. [PDF]

J Virol
Li Y, Yang S, Qian J, Liu S, Li Y, Song X, Cao Q, Guo R, Zhao Y, Sun M, Hu M, Li J, Zhang X, Fan B, Li B.   +14 more
europepmc   +1 more source

Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study. [PDF]

Sci Rep
Fraser DD, Singh D, Cela E, Patel MA, Assaf M, Quintero M, Knauer M, Miller MR, Bellini M, Li A, Hahn P, Hrek M, Cruz-Aguado J.   +12 more
europepmc   +1 more source

SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals. [PDF]

J Virol
Dadonaite B, Burrell AR, Logue J, Chu HY, Payne DC, Haslam DB, Staat MA, Bloom JD.   +7 more
europepmc   +1 more source

Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology. [PDF]

Front Immunol
Tscherne A, Guardado-Calvo P, Clark JJ, Krause R, Krammer F.   +4 more
europepmc   +1 more source

Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display Platform. [PDF]

Antibodies (Basel)
Pan OC, Miller S, Patel R, Mukhopadhyay S, Sarullo G, Go G, Galli J, Hessels J, Schlingmann-Molina B, Ndashimye E, Wen Z, Warren C, Durr E, Zhang L, Vora KA, Fridman A, Chen Z.   +16 more
europepmc   +1 more source

The Inflation Reduction Act and Etanercept

Arthritis &Rheumatology, EarlyView.
Charles L. Bennett, Jason B. Gibbons, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Kevin B. Knopf, Gerald Anderson   +6 more
wiley   +1 more source

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Nature, 2020
David D Ho, Manoj S Nair, Yaoxing Huang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Nature Medicine, 2021
Cyril Planchais, Delphine Planas, Timothée Bruel   +2 more
exaly   +2 more sources